Think.Health

Robeaute is a research and development agency that develops neurosurgical microrobots that can adapt to different types of medical evidence.

Inflammatix develops rapid molecular diagnostics tests that interpret the immune system to resolve major clinical challenges. Initially focused on acute bacterial and viral infections, sepsis, and other conditions like tropical infections and autoimmune diseases.

4TEEN4 Pharmaceuticals develops precision medicines for acute cardiovascular conditions, focusing on restoring cardiac and vascular function in critical care by creating humanized antibodies and related biomarkers and diagnostic tools. Its lead program, Procizumab, is a humanized antibody targeting DPP3 for the treatment of acute cardiovascular diseases. It also develops DPP3 as a diagnostic biomarker for indications such as acute heart failure, myocardial infarction, cardiogenic shock, and septic shock, along with accompanying diagnostic tools. The company evolved from Sphingotec Therapeutics and is based in Hennigsdorf, Germany.

Myo is a communication platform specifically designed for the elderly care sector. The company focuses on enhancing interactions among elderly individuals, their families, and caregivers by providing a user-friendly interface that incorporates traditional messaging features alongside transactional services. This platform facilitates the sharing of photos, videos, texts, and voice messages, allowing caregivers to communicate securely and professionally with relatives. Myo aims to improve the quality of care by fostering closer connections and enhancing communication within the care community. The company is also committed to expanding its team with talented individuals who are passionate about developing products that contribute to better care solutions.

Selfapy develops an online therapy platform focused on treating depression and associated mental health issues. It offers guided, anonymous, and flexible programs, including exercises, videos, and texts, delivered via phone or SMS over three months.

Navignostics is a biotechnology company focused on improving cancer treatment through advanced diagnostic techniques. By employing spatial single-cell proteomics, Navignostics characterizes tumors to identify the most effective treatment strategies for individual cancer patients. The company aims to reduce patient suffering by personalizing cancer therapies and ensuring that the right drug is available for each unique case. In addition to enhancing patient outcomes, Navignostics accelerates cancer drug development by offering valuable insights into drug mechanisms and tumor characteristics, which are essential for the creation of companion diagnostics. Their robust technology and data analytics capabilities position the company as a key player in precision cancer diagnostics, providing support to both patients and pharmaceutical partners in the fight against cancer.

Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early. Vara’s Artificial Intelligence (AI) technology is embedded within the German Breast Cancer Screening Program and is backed by some of the most respected institutions in breast cancer screening in the world including Cambridge (UK), Memorial Sloan (US), and Karolinska (Sweden). Vara’s clinical evidence has also been published in Lancet Digital Health, demonstrating that Vara-assisted radiologists significantly outperform average radiologists and are able to find cancers that would otherwise have been missed. Vara works with healthcare stakeholders, radiology service providers, and medical doctor networks to improve access to high-quality screening in Germany, Egypt, India and Mexico.

Anvajo specializes in point-of-care diagnostic technology. Its portable device combines spectroscopy and microscopy for applications in human/veterinary medicine, food/feed analysis, and environmental/water testing.

Inflammatix develops rapid molecular diagnostics tests that interpret the immune system to resolve major clinical challenges. Initially focused on acute bacterial and viral infections, sepsis, and other conditions like tropical infections and autoimmune diseases.

Myo is a communication platform specifically designed for the elderly care sector. The company focuses on enhancing interactions among elderly individuals, their families, and caregivers by providing a user-friendly interface that incorporates traditional messaging features alongside transactional services. This platform facilitates the sharing of photos, videos, texts, and voice messages, allowing caregivers to communicate securely and professionally with relatives. Myo aims to improve the quality of care by fostering closer connections and enhancing communication within the care community. The company is also committed to expanding its team with talented individuals who are passionate about developing products that contribute to better care solutions.

Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early. Vara’s Artificial Intelligence (AI) technology is embedded within the German Breast Cancer Screening Program and is backed by some of the most respected institutions in breast cancer screening in the world including Cambridge (UK), Memorial Sloan (US), and Karolinska (Sweden). Vara’s clinical evidence has also been published in Lancet Digital Health, demonstrating that Vara-assisted radiologists significantly outperform average radiologists and are able to find cancers that would otherwise have been missed. Vara works with healthcare stakeholders, radiology service providers, and medical doctor networks to improve access to high-quality screening in Germany, Egypt, India and Mexico.

SpinDiag GmbH is a German company specializing in the development of automated point-of-care systems for the rapid detection of infectious diseases. Founded in 2016 and headquartered in Freiburg, SpinDiag manufactures a compact, user-friendly centrifugal-microfluidic test system that enables healthcare professionals to detect drug-resistant bacteria and other pathogens directly from patient samples. Its flagship product, which includes an automated SARS-CoV-2 test, allows for the screening of up to 25 antibiotic resistances upon patient admission, effectively preventing the spread of infections by isolating affected individuals. The system streamlines the testing process with a fully automated workflow that can be operated by nursing staff, providing laboratory-grade PCR results from standard swab samples without the need for additional sample collection. By integrating this technology into everyday clinical practice, SpinDiag enhances diagnostic efficiency and safety in healthcare settings.

Endodont GmbH, founded in 2017 and based in Berlin, Germany, specializes in developing innovative products and processes for the dental industry. The company focuses on enhancing root canal treatments, offering solutions designed to improve root canal fillings through advanced technologies. Their product line includes features such as anti-leakage technology, inflammation-proof techniques, and denser filling materials that provide increased stability. These innovations aim to ensure safer and more efficient dental treatments, ultimately benefiting both patients and dental professionals by reducing treatment times and enhancing overall outcomes.

Selfapy develops an online therapy platform focused on treating depression and associated mental health issues. It offers guided, anonymous, and flexible programs, including exercises, videos, and texts, delivered via phone or SMS over three months.

Caspar Health is a company focused on enhancing rehabilitation accessibility through its digital platform, which allows patients to receive care remotely after an illness or accident. The platform offers a variety of preconfigured therapy plans tailored to specific medical conditions, including movement exercises, seminars, and relaxation modules. This enables healthcare professionals to deliver effective and sustainable treatment regardless of the patient's location or time constraints. Recognized as a provider of tele-rehabilitation aftercare by the German Pension Fund, Caspar Health sets new standards in digital rehabilitation, promoting independence and recovery for individuals seeking to regain their quality of life.

Inflammatix develops rapid molecular diagnostics tests that interpret the immune system to resolve major clinical challenges. Initially focused on acute bacterial and viral infections, sepsis, and other conditions like tropical infections and autoimmune diseases.

M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.

First Light Diagnostics Inc. is a medical diagnostics company focused on developing automated products for the rapid detection of pathogens responsible for healthcare-associated infections. Based in Chelmsford, Massachusetts, the company offers a benchtop MultiPath analyzer, which is designed for hospital clinical microbiology laboratories and can identify both resistant and sensitive strains of Staphylococcus aureus, as well as various toxins and viruses. Their innovative diagnostic solutions address the increasing demand for accurate and cost-effective testing, which has been shown to significantly reduce hospital infection rates. First Light's proprietary MultiPath detection technology combines the performance of advanced laboratory tests with enhanced affordability and user-friendliness. By providing antimicrobial susceptibility tests that deliver results within hours, the company enables healthcare professionals to administer appropriate antibiotic treatments quickly, ultimately saving lives, reducing healthcare costs, and improving antibiotic stewardship. First Light Diagnostics was incorporated in 2006 and was formerly known as First Light Biosciences Inc. before its name change in January 2019.

PreOmics GmbH is a biotechnology company based in Planegg, Germany, specializing in mass spectrometry (MS)-based proteomics. Founded in 2016 as a spin-off from the Max-Planck Institute of Biochemistry, PreOmics develops innovative tools and technologies aimed at enhancing protein analysis for researchers worldwide. The company's flagship product, the iST Kit, facilitates rapid and reproducible preparation of peptide mixtures from various starting materials, streamlining the sample preparation process within just one hour. PreOmics also offers high-throughput processing accessories and a robust platform that leverages liquid chromatography coupled with mass spectrometry to enable comprehensive protein identification, quantification, and analysis of post-translational modifications. Through its advanced solutions, PreOmics supports the scientific community in accelerating discovery and understanding of protein interactions and functions.

Myo is a communication platform specifically designed for the elderly care sector. The company focuses on enhancing interactions among elderly individuals, their families, and caregivers by providing a user-friendly interface that incorporates traditional messaging features alongside transactional services. This platform facilitates the sharing of photos, videos, texts, and voice messages, allowing caregivers to communicate securely and professionally with relatives. Myo aims to improve the quality of care by fostering closer connections and enhancing communication within the care community. The company is also committed to expanding its team with talented individuals who are passionate about developing products that contribute to better care solutions.

Inflammatix develops rapid molecular diagnostics tests that interpret the immune system to resolve major clinical challenges. Initially focused on acute bacterial and viral infections, sepsis, and other conditions like tropical infections and autoimmune diseases.

Selfapy develops an online therapy platform focused on treating depression and associated mental health issues. It offers guided, anonymous, and flexible programs, including exercises, videos, and texts, delivered via phone or SMS over three months.

M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.

Omnicare Pharma is a pharmaceutical wholesaler specializing in the distribution of finished medicinal products to compounding pharmacies for the patient-specific production of cancer drugs, supporting outpatient oncology care.

Founded in Berlin, Germany in 2016, Smarterials designs and manufactures advanced medical gloves. Their dual-barrier gloves actively alert healthcare professionals to infection risks via perforation indicators, enhancing protection and reducing costs associated with contamination.

Caspar Health is a company focused on enhancing rehabilitation accessibility through its digital platform, which allows patients to receive care remotely after an illness or accident. The platform offers a variety of preconfigured therapy plans tailored to specific medical conditions, including movement exercises, seminars, and relaxation modules. This enables healthcare professionals to deliver effective and sustainable treatment regardless of the patient's location or time constraints. Recognized as a provider of tele-rehabilitation aftercare by the German Pension Fund, Caspar Health sets new standards in digital rehabilitation, promoting independence and recovery for individuals seeking to regain their quality of life.

Endodont GmbH, founded in 2017 and based in Berlin, Germany, specializes in developing innovative products and processes for the dental industry. The company focuses on enhancing root canal treatments, offering solutions designed to improve root canal fillings through advanced technologies. Their product line includes features such as anti-leakage technology, inflammation-proof techniques, and denser filling materials that provide increased stability. These innovations aim to ensure safer and more efficient dental treatments, ultimately benefiting both patients and dental professionals by reducing treatment times and enhancing overall outcomes.

M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.

HelloCare is an online care and support marketplace that helps users find caregivers and domestic helpers in their cities. People can select the day, time, and the scope of services; receive a personal message with information on the representative or domestic helper assigned for them; visit the online profile of the candidate and see the reviews of other customers; and make payments via online tools to book the service. HelloCare enables independent caregivers and domestic workers to register as partners, access customer orders, and work without a direct boss.

Caspar Health is a company focused on enhancing rehabilitation accessibility through its digital platform, which allows patients to receive care remotely after an illness or accident. The platform offers a variety of preconfigured therapy plans tailored to specific medical conditions, including movement exercises, seminars, and relaxation modules. This enables healthcare professionals to deliver effective and sustainable treatment regardless of the patient's location or time constraints. Recognized as a provider of tele-rehabilitation aftercare by the German Pension Fund, Caspar Health sets new standards in digital rehabilitation, promoting independence and recovery for individuals seeking to regain their quality of life.

HyHelp AG is a company based in Frankfurt am Main, Germany, that specializes in developing mobile devices and software tools for hygiene management in healthcare settings. Its innovative device is designed to assist healthcare professionals, including doctors and nurses, in enhancing hand hygiene practices, thereby reducing the incidence of nosocomial infections and improving overall patient safety. By enabling hospitals and other healthcare institutions to effectively track and monitor hand hygiene events, HyHelp plays a crucial role in promoting better hygiene standards within the medical community.

HyHelp AG is a company based in Frankfurt am Main, Germany, that specializes in developing mobile devices and software tools for hygiene management in healthcare settings. Its innovative device is designed to assist healthcare professionals, including doctors and nurses, in enhancing hand hygiene practices, thereby reducing the incidence of nosocomial infections and improving overall patient safety. By enabling hospitals and other healthcare institutions to effectively track and monitor hand hygiene events, HyHelp plays a crucial role in promoting better hygiene standards within the medical community.

Pedanios GmbH is a Berlin-based company specializing in the distribution of pharmaceutical products, with a particular focus on licensed narcotic drugs. Founded in 2015, Pedanios ensures high-quality medicines reach patients through rigorous selection of producers and extensive quality and safety measures. The company collaborates with specialized logistics partners for efficient product delivery. In December 2016, Cronos Group entered into an exclusive European supply agreement with Pedanios, designating Cronos as the sole North American supplier of cannabis products to Pedanios for distribution within the European Union.

Urban Sports Club operates a membership-based platform that provides access to fitness studios, classes, and health activities through an extensive network of partner facilities across Europe. The service offers a flexible sports flat-rate with access to more than 50 activity types and over 10,000 partner venues in multiple European countries, supporting both individual and corporate users to pursue varied workouts, team sports, wellness, and related activities under one membership.